PHASE-I AND PHARMACOKINETIC STUDY OF 5-AZA-2'-DEOXYCYTIDINE (NSC 127716) IN CANCER-PATIENTS

被引：1
|
作者：
VANGROENINGEN, CJ
LEYVA, A
OBRIEN, AMP
GALL, HE
PINEDO, HM
机构：
来源：
CANCER RESEARCH | 1986年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4831 / 4836
页数：6
相关论文
共 50 条
  • [31] PHASE-II STUDY OF 5-AZA-2'-DEOXYCYTIDINE IN ADVANCED OVARIAN-CARCINOMA
    SESSA, C
    HUININK, WT
    STOTER, G
    RENARD, J
    CAVALLI, F
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 137 - 138
  • [32] PHASE-I STUDY OF ALIZAPRIDE IN CANCER-PATIENTS UNDER CISPLATINUM
    NICAISE, C
    ROZENCWEIG, M
    ORTMANS, M
    FRISQUE, C
    BLEIBERG, H
    SEMAINE DES HOPITAUX, 1983, 59 (31): : 2161 - 2165
  • [33] PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR SODIUM (NSC-368390)
    NOE, DA
    ROWINSKY, EK
    SHEN, HSL
    CLARKE, BV
    GROCHOW, LB
    MCGUIRE, WB
    HANTEL, A
    ADAMS, DB
    ABELOFF, MD
    ETTINGER, DS
    DONEHOWER, RC
    CANCER RESEARCH, 1990, 50 (15) : 4595 - 4599
  • [34] THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP EXPERIENCE WITH 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN PATIENTS WITH COLO-RECTAL, HEAD AND NECK, RENAL CARCINOMAS AND MALIGNANT MELANOMAS
    ABELE, R
    CLAVEL, M
    DODION, P
    BRUNTSCH, U
    GUNDERSEN, S
    SMYTH, J
    RENARD, J
    VANGLABBEKE, M
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12): : 1921 - 1924
  • [35] DIFLUOROMETHYLORNITHINE AND LEUKOCYTE INTERFERON - A PHASE-I STUDY IN CANCER-PATIENTS
    TALPAZ, M
    PLAGER, C
    QUESADA, J
    BENJAMIN, R
    KANTARJIAN, H
    GUTTERMAN, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 685 - 689
  • [36] PEDIATRIC PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF TIAZOFURIN (NSC 286193)
    BALIS, FM
    LANGE, BJ
    PACKER, RJ
    HOLCENBERG, JS
    ETTINGER, LJ
    SALLAN, SE
    HEIDEMAN, RL
    ZIMM, S
    SMITHSON, WA
    COGLIANOSHUTTA, NA
    REAMAN, GH
    POPLACK, DG
    CANCER RESEARCH, 1985, 45 (10) : 5169 - 5172
  • [37] 5-AZA-2′-DEOXYCYTIDINE IS A POTENTIAL INHIBITOR OF HUMAN PROSTATE CANCER INVASION
    Chen, Lin
    Zhang, Qiang
    Helfand, Brian
    Sharma, Vidit
    Qin, Weijun
    Brendler, Charles
    Zhu, Lihua
    Kundu, Shilajit D.
    Jiang, Thomas
    Zhang, Weipeng
    Lee, Bob
    Randall-London, Sherin
    Jovanovic, Borko
    Yang, Ximing J.
    Kozlowski, James
    Kuzel, Timothy Michael
    Guo, Yinglu
    Lee, Chung
    JOURNAL OF UROLOGY, 2011, 185 (04): : E168 - E168
  • [38] Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
    F Meng
    G Sun
    M Zhong
    Y Yu
    M A Brewer
    British Journal of Cancer, 2013, 108 : 579 - 586
  • [39] A phase II study of 5-aza-2′deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer
    Thibault, A
    Figg, WD
    Bergan, RC
    Lush, RM
    Myers, CE
    Tompkins, A
    Reed, E
    Samid, D
    TUMORI, 1998, 84 (01) : 87 - 89
  • [40] 5-aza-2′-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines
    Kanda, T
    Tada, M
    Imazeki, F
    Yokosuka, O
    Nagao, K
    Saisho, H
    ONCOLOGY REPORTS, 2005, 14 (04) : 975 - 979
12345